In yesterday’s Wall Street session, Vera Therapeutics Inc (NASDAQ:VERA) shares traded at $48.83, up 2.89% from the previous session.
VERA stock price is now 11.14% away from the 50-day moving average and 19.73% away from the 200-day moving average. The market capitalization of the company currently stands at $3.09B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $70, Wells Fargo recently initiated with Overweight rating for Vera Therapeutics Inc (NASDAQ: VERA). , while ‘Oppenheimer’ rates the stock as ‘Outperform’
In other news, Fordyce Marshall, PRESIDENT AND CEO sold 19,375 shares of the company’s stock on Nov 25 ’24. The stock was sold for $929,560 at an average price of $47.98. Upon completion of the transaction, the PRESIDENT AND CEO now directly owns 85,942 shares in the company, valued at $4.2 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 25 ’24, Director MARSHALL FORDYCE bought 19,375 shares of the business’s stock. A total of $936,006 was incurred on buying the stock at an average price of $48.31. A total of 26.04% of the company’s stock is owned by insiders.
During the past 12 months, Vera Therapeutics Inc has had a low of $12.28 and a high of $51.61. As of last week, the company has a debt-to-equity ratio of 0.19, a current ratio of 13.60, and a quick ratio of 13.60. The fifty day moving average price for VERA is $43.7664 and a two-hundred day moving average price translates $40.7541 for the stock.
The latest earnings results from Vera Therapeutics Inc (NASDAQ: VERA) was released for 2024-09-30. The company reported revenue of $49.8 million for the quarter, compared to $21.76 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 128.91 percent.
